Skip to main content

sec filings

Insider trades

Open-market buys and sales that company insiders report to the SEC on .

Side
Planned sales
Role
OKUR

Updated 10/6/2026, 9:41 AM ET.

OKUR

OnKure Therapeutics, Inc.

Sale$259

Saccomano Nicholas A

President and CEO, Director

87 shat $2.97Filed Sep 23, 4:54 PM ETFiling
OKUR

OnKure Therapeutics, Inc.

Sale$898

Leverone Jason A.

Chief Financial Officer

302 shat $2.97Filed Sep 23, 4:52 PM ETFiling

Read from public SEC filings. Not financial advice.